Legend Biotech Corp (LEGN) stock
LEGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 10, 2026Score 3/30
$16.25+0.14 (+0.87%)
Close on Nov 18, 2026Market cap $3.01BP/E –Yield –
Legend Biotech enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Legend Biotech's enterprise value was $3.14B on Nov 11, 2026, against $5.13B a year earlier. Over the last 5 years it ranged from $2.75B to $11.49B, with a median of $6.42B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.14B | -22.2% |
| 2025 | Dec 31, 2025 | $4.04B | -30.1% |
| 2024 | Dec 31, 2024 | $5.77B | -40.2% |
| 2023 | Dec 29, 2023 | $9.65B | +49.4% |
| 2022 | Dec 30, 2022 | $6.46B | +28.3% |
| 2021 | Dec 31, 2021 | $5.04B | +84.3% |
| 2020 | Dec 31, 2020 | $2.73B | – |
See a number that looks wrong?